Insider · CIK 0001822507
Patrick A Sturgeon
Files at XAGE (Carmell Corp). First filing Dec 8, 2023, latest Dec 18, 2023.
In brief
Patrick A Sturgeon files SEC Form 4 as director at XAGE (Carmell Corp). Since Dec 8, 2023, Patrick A Sturgeon has reported 3 open-market buys worth $25k and 0 open-market sells worth $0, the latest filed on Dec 18, 2023.
A track record needs three past buys with six months of prices behind them; Patrick A Sturgeon has 0, so none is measured yet.
The newest scored trade: bought $4,320 of XAGE on Dec 14, 2023, filed Dec 18, 2023, scored 49 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XAGE: Carmell Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | Carmell Corp | $4,320 1,130 shares | +20% | +125% from low-65% from high | |
| 53Moderate | Carmell Corp | $14k 3,261 shares | +140% | +108% from low-68% from high | |
| 46Moderate | Carmell Corp | $7,086 2,336 shares | - | +81% from low-72% from high |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 11, 2024 | XAGE Carmell Corp | AGrant or award Stock Option (right to buy)derivative | +76,878 | $0.00 | $0 | 76,878 | Nov 8, 2024 |
| Dec 14, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +391 | $3.61 | $1,412 | 5,988 | Dec 18, 2023 |
| Dec 15, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +739 | $3.94 | $2,908 | 6,727 | Dec 18, 2023 |
| Dec 11, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +1,087 | $3.53 | $3,834 | 3,423 | Dec 13, 2023 |
| Dec 12, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +1,087 | $3.50 | $3,806 | 4,510 | Dec 13, 2023 |
| Dec 13, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +1,087 | $5.57 | $6,056 | 5,597 | Dec 13, 2023 |
| Dec 4, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +1,087 | $3.00 | $3,259 | 1,087 | Dec 8, 2023 |
| Dec 5, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +347 | $3.10 | $1,077 | 1,434 | Dec 8, 2023 |
| Dec 6, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +608 | $3.03 | $1,844 | 2,042 | Dec 8, 2023 |
| Dec 7, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +248 | $3.07 | $760 | 2,290 | Dec 8, 2023 |
| Dec 8, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stockindirect: By Carmell Insiders LLC | +46 | $3.15 | $145 | 2,336 | Dec 8, 2023 |
Questions about Patrick A Sturgeon
Answered from the filings on this page, as of the latest one.
Is Patrick A Sturgeon buying or selling?
Not in the last 12 months. Patrick A Sturgeon's latest open-market trade on SEC Form 4 was bought $4,320 of XAGE on Dec 14, 2023.
How did Patrick A Sturgeon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patrick A Sturgeon has 0.
Where does Patrick A Sturgeon file Form 4?
Patrick A Sturgeon has filed Form 4 at XAGE (Carmell Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.